The N-Myc down regulated Gene1 (NDRG1) Is a Rab4a effector involved in vesicular recycling of E-cadherin.

Preclinical and clinical studies with the multi-kinase inhibitor CEP-701 as treatment for prostate cancer demonstrate the inadequacy of PSA response as a primary endpoint.

Cytotoxic phenylpropanoids and an additional thapsigargin analogue isolated from Thapsia garganica.

Phase II evaluation of docetaxel plus exisulind in patients with androgen independent prostate carcinoma.

Synthesis and screening of a random dimeric peptide library using the one-bead-one-dimer combinatorial approach.

Pharmacokinetics, biodistribution, and antitumor efficacy of a human glandular kallikrein 2 (hK2)-activated thapsigargin prodrug.

Anti-tumor effect of combination therapy with intratumoral controlled-release paclitaxel (PACLIMER microspheres) and radiation.

The impact of usual dietary patterns, selection of significant foods and cuisine choices on changing dietary fat under 'free living' conditions.

A 5-fluorodeoxyuridine prodrug as targeted therapy for prostate cancer.

A supramicromolar elevation of intracellular free calcium ([Ca(2+)](i)) is consistently required to induce the execution phase of apoptosis.